These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29411596)

  • 1. [Antidote treatment during use of direct anticoagulants].
    Rutherford OW; König MSS; Risnes K; Raouf N; Atar D; Ghanima W
    Tidsskr Nor Laegeforen; 2018 Feb; 138(3):. PubMed ID: 29411596
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiology Patient Pages: Antidotes for Bleeding Caused by Novel Oral Anticoagulants.
    Pollack CV
    Circulation; 2016 Jan; 133(2):e18-9. PubMed ID: 27028439
    [No Abstract]   [Full Text] [Related]  

  • 3. [Not Available].
    Själander S; Själander A
    Lakartidningen; 2018 Dec; 115():. PubMed ID: 30512136
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment with inhibitors of new oral direct anticoagulants in patients with severe bleedings or urgent surgical procedures. The new dabigatran antidote: the place of idarucizumab in clinical practice].
    Boda Z
    Orv Hetil; 2016 Mar; 157(12):443-50. PubMed ID: 26971644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of reversal agents for direct oral anticoagulants.
    Monagle S; Eikelboom JW; Ng KH; Bhagirath VC
    Future Cardiol; 2017 Mar; 13(2):153-159. PubMed ID: 28198201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [NOAC: Real-life data and the role of antidotes for the treatment of bleeding].
    Darius H
    Med Klin Intensivmed Notfmed; 2017 Mar; 112(2):99-104. PubMed ID: 28144725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idarucizumab and factor Xa reversal agents: role in hospital guidelines and protocols.
    Huisman MV; Fanikos J
    Am J Emerg Med; 2016 Nov; 34(11S):46-51. PubMed ID: 27697438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Security profile of direct anticoagulants. Preferred use in atrial fibrillation.
    Roldán Rabadán I; Alonso de Leciñana M; Barba Martín R; Páramo Fernández JA;
    Clin Investig Arterioscler; 2019; 31(6):263-270. PubMed ID: 31213323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleeding management in patients with new oral anticoagulants.
    Vargas M; Marra A; Perrone A; Servillo G
    Minerva Anestesiol; 2016 Aug; 82(8):884-94. PubMed ID: 27124307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bleeding and surgery in the treatment with new oral anticoagulants. The management can be complicated by the lack of specific antidotes].
    Dalén M; Hjemdahl P; Holmström M; Ivert T
    Lakartidningen; 2014 Jun 11-17; 111(24):1064-8. PubMed ID: 25129916
    [No Abstract]   [Full Text] [Related]  

  • 11. [Not Available].
    Simeon L; Wuillemin WA
    Ther Umsch; 2016; 73(10):561-566. PubMed ID: 28045358
    [No Abstract]   [Full Text] [Related]  

  • 12. [Management of bleeding associated with direct oral anticoagulants: update on reversal strategies].
    Enríquez A; Baranchuk A; Corbalán R
    Rev Med Chil; 2019; 147(1):73-82. PubMed ID: 30848768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal agents for oral anticoagulants.
    Griffiths CL; Vestal ML; Livengood SJ; Hicks S
    Nurse Pract; 2017 Nov; 42(11):8-14. PubMed ID: 28957948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peri-Interventional Management of Direct Oral Anticoagulants - Balancing Benefits and Risks].
    Dülgeroglu J; Schmidt D
    Praxis (Bern 1994); 2018 Apr; 107(9-10):485-493. PubMed ID: 29690851
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacologic Reversal of Direct Oral Anticoagulants.
    Farina N; Miller JT
    Crit Care Nurs Q; 2018; 41(2):121-128. PubMed ID: 29494368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monitoring options and reversal agents for oral anticoagulants].
    Thorup SB; Husted SE; Vang ML
    Ugeskr Laeger; 2014 Apr; 176(9):. PubMed ID: 25096568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidotes to non-vitamin K oral anticoagulants: necessary or not?
    Proietti M; Lip GY
    Expert Opin Pharmacother; 2015; 16(11):1573-6. PubMed ID: 26077323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel oral anticoagulants in plastic surgery.
    Munson CF; Reid AJ
    J Plast Reconstr Aesthet Surg; 2016 May; 69(5):585-93. PubMed ID: 27013144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bleeding with Direct Oral Anticoagulants vs Warfarin: Clinical Experience.
    Eikelboom J; Merli G
    Am J Med; 2016 Nov; 129(11S):S33-S40. PubMed ID: 27586367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct oral anticoagulants and the bleeding patient.
    Wood B; Sholzberg M; Ackery A
    CMAJ; 2016 Feb; 188(3):215. PubMed ID: 26464134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.